1. Home
  2. CMCM vs MDWD Comparison

CMCM vs MDWD Comparison

Compare CMCM & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMCM
  • MDWD
  • Stock Information
  • Founded
  • CMCM 2009
  • MDWD 2000
  • Country
  • CMCM China
  • MDWD Israel
  • Employees
  • CMCM N/A
  • MDWD N/A
  • Industry
  • CMCM Computer Software: Prepackaged Software
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • CMCM Technology
  • MDWD Health Care
  • Exchange
  • CMCM Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • CMCM 196.4M
  • MDWD 208.2M
  • IPO Year
  • CMCM 2014
  • MDWD 2014
  • Fundamental
  • Price
  • CMCM $8.72
  • MDWD $17.09
  • Analyst Decision
  • CMCM
  • MDWD Strong Buy
  • Analyst Count
  • CMCM 0
  • MDWD 2
  • Target Price
  • CMCM N/A
  • MDWD $35.00
  • AVG Volume (30 Days)
  • CMCM 87.6K
  • MDWD 160.1K
  • Earning Date
  • CMCM 09-11-2025
  • MDWD 08-14-2025
  • Dividend Yield
  • CMCM N/A
  • MDWD N/A
  • EPS Growth
  • CMCM N/A
  • MDWD N/A
  • EPS
  • CMCM N/A
  • MDWD N/A
  • Revenue
  • CMCM $137,272,956.00
  • MDWD $19,858,000.00
  • Revenue This Year
  • CMCM $14.27
  • MDWD $20.37
  • Revenue Next Year
  • CMCM $39.26
  • MDWD $25.91
  • P/E Ratio
  • CMCM N/A
  • MDWD N/A
  • Revenue Growth
  • CMCM 38.54
  • MDWD N/A
  • 52 Week Low
  • CMCM $3.28
  • MDWD $14.14
  • 52 Week High
  • CMCM $9.39
  • MDWD $22.51
  • Technical
  • Relative Strength Index (RSI)
  • CMCM 70.91
  • MDWD 45.48
  • Support Level
  • CMCM $7.80
  • MDWD $16.85
  • Resistance Level
  • CMCM $9.39
  • MDWD $20.30
  • Average True Range (ATR)
  • CMCM 0.62
  • MDWD 0.95
  • MACD
  • CMCM 0.24
  • MDWD 0.15
  • Stochastic Oscillator
  • CMCM 82.73
  • MDWD 23.93

About CMCM Cheetah Mobile Inc. each representing fifty (50)

Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: